These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 11204288)

  • 1. Antihypertensive pharmacogenetics: getting the right drug into the right patient.
    Turner ST; Schwartz GL; Chapman AB; Hall WD; Boerwinkle E
    J Hypertens; 2001 Jan; 19(1):1-11. PubMed ID: 11204288
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacogenetics of antihypertensive drug responses.
    Schwartz GL; Turner ST
    Am J Pharmacogenomics; 2004; 4(3):151-60. PubMed ID: 15174896
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacogenetics of antihypertensive treatment.
    Arnett DK; Claas SA; Glasser SP
    Vascul Pharmacol; 2006 Feb; 44(2):107-18. PubMed ID: 16356784
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacogenetics of antihypertensive drug response.
    Kreutz R
    Curr Hypertens Rep; 2004 Feb; 6(1):15-20. PubMed ID: 14972084
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antihypertensive pharmacogenetics.
    Nogueira JB
    Rev Port Cardiol; 2004 Dec; 23(12):1621-30. PubMed ID: 15732663
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlation of renin angiotensin system (RAS) candidate gene polymorphisms with response to Ramipril in patients with essential hypertension.
    Gupta S; Chattopadhyaya I; Agrawal BK; Sehajpal PK; Goel RK
    J Postgrad Med; 2015; 61(1):21-6. PubMed ID: 25511213
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Individual sensitivity to antihypertensive drugs: genetic aspects].
    Minushkina LO; Zateĭshchikov DA; Sidorenko BA
    Kardiologiia; 2005; 45(7):58-65. PubMed ID: 16091664
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Computational and Pharmacogenomic Insights on Hypertension Treatment: Rational Drug Design and Optimization Strategies.
    Loganathan L; Gopinath K; Sankaranarayanan VM; Kukreti R; Rajendran K; Lee JK; Muthusamy K
    Curr Drug Targets; 2020; 21(1):18-33. PubMed ID: 31393243
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genes and hypertension.
    Garcia EA; Newhouse S; Caulfield MJ; Munroe PB
    Curr Pharm Des; 2003; 9(21):1679-89. PubMed ID: 12871201
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Individualized tailoring of antihypertensive therapy].
    Nakazawa I; Umemura S
    Nihon Rinsho; 2002 Jan; 60(1):137-42. PubMed ID: 11808324
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacogenomics of hypertension.
    Cadman PE; O'Connor DT
    Curr Opin Nephrol Hypertens; 2003 Jan; 12(1):61-70. PubMed ID: 12496668
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gene markers and antihypertensive therapy.
    Turner ST; Schwartz GL
    Curr Hypertens Rep; 2005 Feb; 7(1):21-30. PubMed ID: 15683583
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An update on the pharmacogenetics of treating hypertension.
    Fontana V; Luizon MR; Sandrim VC
    J Hum Hypertens; 2015 May; 29(5):283-91. PubMed ID: 25355012
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The antihypertensive response to irbesartan treatment from a pharmacogenetic perspective.
    Kurland L
    Minerva Med; 2003 Aug; 94(4):251-8. PubMed ID: 14605589
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical and molecular approaches to individualize antihypertensive drug therapy.
    Hiltunen TP; Kontula K
    Ann Med; 2012 Jun; 44 Suppl 1():S23-9. PubMed ID: 22713145
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of antihypertensive drugs and gene variants in the renin-angiotensin system.
    Katsuya T; Iwashima Y; Sugimoto K; Motone M; Asai T; Fukuda M; Fu Y; Hatanaka Y; Ohishi M; Rakugi H; Higaki J; Ogihara T
    Hypertens Res; 2001 Jul; 24(4):463-7. PubMed ID: 11510761
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacogenomics of hypertension: a genome‐wide, placebo‐controlled cross‐over study, using four classes of antihypertensive drugs.
    Hiltunen TP; Donner KM; Sarin AP; Saarela J; Ripatti S; Chapman AB; Gums JG; Gong Y; Cooper-DeHoff RM; Frau F; Glorioso V; Zaninello R; Salvi E; Glorioso N; Boerwinkle E; Turner ST; Johnson JA; Kontula KK
    J Am Heart Assoc; 2015 Jan; 4(1):e001521. PubMed ID: 25622599
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetics of hypertension. Therapeutic implications.
    O'Byrne S; Caulfield M
    Drugs; 1998 Aug; 56(2):203-14. PubMed ID: 9711445
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Renin-angiotensin system and alpha-adducin gene polymorphisms and their relation to responses to antihypertensive drugs: results from the GENRES study.
    Suonsyrjä T; Hannila-Handelberg T; Fodstad H; Donner K; Kontula K; Hiltunen TP
    Am J Hypertens; 2009 Feb; 22(2):169-75. PubMed ID: 19057513
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prediction of patient responses to antihypertensive drugs using genetic polymorphisms: investigation of renin-angiotensin system genes.
    Dudley C; Keavney B; Casadei B; Conway J; Bird R; Ratcliffe P
    J Hypertens; 1996 Feb; 14(2):259-62. PubMed ID: 8728305
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.